IFNG and COVID-19: Although it has been reported that durable spike-specific T-cell responses after different COVID-19 primary vaccination regimens are not further enhanced by an mRNA booster23, results presented here show that ARVAC CG booster significantly increases the proportion of antigen-specific IFN-γ and IL-4 producing T cells in individuals previously vaccinated with different primary schemes.